WebCompany Description: NovaBay Pharmaceuticals aims to keep the "bed bugs" away. The clinical-stage biopharmaceutical company develops antimicrobial compounds (known as Aganocide compounds) for the treatment and prevention of infections in hospital and non-hospital environments. Aganocide compounds destroy bacteria by attacking multiple … WebMay 14, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the …
NovaBay Pharmaceuticals NYSEAM:NBY Stock Report - Simply …
WebSEC Filings. For filings please visit: United States: SEC Filings Canada: SEDAR Filings WebJul 13, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the ... agna motors
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
WebMay 17, 2024 · NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray ... WebReviews from NovaBay Pharmaceuticals Inc employees about NovaBay Pharmaceuticals Inc culture, salaries, benefits, work-life balance, management, job security, and more. ... The most useful review selected by Indeed. Start up business with inadequate resources to grow the business. Management continued to make changes in an effort to change the ... WebMar 27, 2024 · NovaBay recorded a loss attributable to common shareholders for the 2024 fourth quarter of $3.5 million or $0.13 per share. This compares with a net loss for the 2024 fourth quarter of $1.3... agnani caste